Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAxsome Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Axsome Therapeutics, Inc.

$172.97Close · Oct 7, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $218.38M. Net result −$51.31M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $218.38M. Running result $218.38M. Product: $216.36M. Royalty And Milestone Revenue: $2.02M.
  • Cost of revenue: −$13.56M. Running result $204.81M.
  • Gross profit: $204.81M. Running result $204.81M.
  • Research and development: −$46.23M. Running result $158.58M.
  • Selling, general and administrative: −$208.14M. Running result −$49.55M.
  • Gain in fair value of contingent consideration: $1.5M. Running result −$48.06M.
  • Intangible asset amortization: −$1.59M. Running result −$49.65M.
  • Operating income: −$49.65M. Running result −$49.65M.
  • Other expense: −$1.54M. Running result −$51.19M.
  • Pre-tax loss: −$51.19M. Running result −$51.19M.
  • Income tax expense: −$128K. Running result −$51.31M.
  • Net loss: −$51.31M. Running result −$51.31M.